Antibe Therapeutics Stock (OTC:ATBPF), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for Antibe Therapeutics

No data available to display

date ▲▼	ticker ▲▼	Buy Now	Company ▲▼	Current price ▲▼	Upside/Downside ▲▼	Analyst Firm ▲▼	Analyst & % Accurate ▲▼	Price Target Change ▲▼	Rating Change ▲▼	Previous / Current Rating ▲▼	Get Alert

FAQ

What is the target price for Antibe Therapeutics (ATBPF)?

There is no price target for Antibe Therapeutics.

What is the most recent analyst rating for Antibe Therapeutics (ATBPF)?

There is no analyst for Antibe Therapeutics.

When was the last upgrade for Antibe Therapeutics (ATBPF)?

There is no last upgrade for Antibe Therapeutics.

When was the last downgrade for Antibe Therapeutics (ATBPF)?

There is no last downgrade for Antibe Therapeutics.

When is the next analyst rating going to be posted or updated for Antibe Therapeutics (ATBPF)?

There is no next analyst rating for Antibe Therapeutics.

Is the Analyst Rating Antibe Therapeutics (ATBPF) correct?